Advances in models predicting efficacy of immune checkpoint inhibitors
The use of immune checkpoint inhibitor (ICI) has revolutionized the treatment among patients with various types of tumors. However, only some patients can benefit from ICI. The identification of predictive markers of response to treatment in patients is required, such as programmed death ligand-1 (P...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2023-01-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1676258288704-857777667.pdf |